Demographic and clinical characteristicsa.

aValues are expressed as No. (%) or median (interquartile range).bStandardized T scores based on normative data.cPrevious or current disease involving the CNS, psychiatric disorder, psychopharmacologic treatment, and drug use.Abbreviations: MSM, men who have sex with men; CDC, Centers for Disease Control and Prevention; ARV, antiretroviral; PIs, protease inhibitors; NRTIs, nucleoside reverse transcriptase inhibitors; NNRTIs, nonnucleoside reverse transcriptase inhibitors; LPV/r, lopinavir/ritonavir; LPV/r-MT, lopinavir/ritonavir monotherapy; LPV/r-ART, lopinavir/ritonavir triple-therapy; TDF, tenofovir; FTC, emtricitabine; ABC, abacavir, 3TC, lamivudine; AZT, zidovudine; ddI, didanosine; VL, viral load; WAIS-III, Wechsler Adult Intelligence Scale-III; Beck Depression Inventory; STAI, State-Trait Anxiety Inventory.a 数据以例数（百分比）或中位数（四分位间距）表示。b 基于常模数据的标准化T评分。c 中枢神经系统既往或现患疾病、精神障碍、精神药物治疗及药物使用情况。缩略语：男男性行为者（men who have sex with men, MSM）；美国疾病控制与预防中心（Centers for Disease Control and Prevention, CDC）；抗反转录病毒药物（antiretroviral, ARV）；蛋白酶抑制剂（protease inhibitors, PIs）；核苷类反转录酶抑制剂（nucleoside reverse transcriptase inhibitors, NRTIs）；非核苷类反转录酶抑制剂（nonnucleoside reverse transcriptase inhibitors, NNRTIs）；洛匹那韦/利托那韦（lopinavir/ritonavir, LPV/r）；洛匹那韦/利托那韦单药治疗（lopinavir/ritonavir monotherapy, LPV/r-MT）；洛匹那韦/利托那韦三联治疗（lopinavir/ritonavir triple-therapy, LPV/r-ART）；替诺福韦（tenofovir, TDF）；恩曲他滨（emtricitabine, FTC）；阿巴卡韦（abacavir, ABC）；拉米夫定（lamivudine, 3TC）；齐多夫定（zidovudine, AZT）；去羟肌苷（didanosine, ddI）；病毒载量（viral load, VL）；韦氏成人智力量表第三版（Wechsler Adult Intelligence Scale-III, WAIS-III）；贝克抑郁量表（Beck Depression Inventory）；状态-特质焦虑量表（State-Trait Anxiety Inventory, STAI）。